NCT06054347 - Evaluation by a Vineland II Scale of Long-term Development of Children With Pyridoxine Dependent Epilepsy | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

December 29, 2023

Primary Completion Date

May 21, 2025

Study Completion Date

May 21, 2025

Conditions

Pyridoxine-Dependent Epilepsy

Interventions

OTHER

VINELAND II

Standardised questionnaire filled by the investigator during an interview with the parents or with the patient himself if capable of it. Duration 1 hour to 1 hour and a half.

Trial Locations (12)

13005

Hôpital de la Timone-Enfants, Marseille

25030

Centre Hospitalier Universitaire de Besançon, Besançon

29609

CHRU Morvan, Brest

31100

CHU Toulouse, Toulouse

34295

CHU Gui de Chautiac, Montpeliier

37000

Hôpital Clocheville, Tours

44600

Centre Hospitalier Saint Nazaire, Saint-Nazaire

49100

CHU Angers, Angers

59037

Hôpital Jeanne de Flandre, Lille

63003

CHU d'Estaing, Clermont-Ferrand

75749

Hôpital Necker-Enfants malades, Paris

94270

Hôpital Bicêtre, Le Kremlin-Bicêtre

All Listed Sponsors

lead

University Hospital, Angers

OTHER_GOV